LEADER 04555nam 2200649 450 001 9910463842803321 005 20200520144314.0 010 $a0-19-180182-8 010 $a0-19-165139-7 035 $a(CKB)2670000000571672 035 $a(EBL)1816432 035 $a(OCoLC)893653925 035 $a(SSID)ssj0001411744 035 $a(PQKBManifestationID)11803957 035 $a(PQKBTitleCode)TC0001411744 035 $a(PQKBWorkID)11401599 035 $a(PQKB)10155949 035 $a(MiAaPQ)EBC1816432 035 $a(StDuBDS)EDZ0001098136 035 $a(Au-PeEL)EBL1816432 035 $a(CaPaEBR)ebr10954059 035 $a(CaONFJC)MIL651923 035 $a(EXLCZ)992670000000571672 100 $a20141021h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aImaging in neurodegenerative disorders /$fedited by Luca Saba 205 $aFirst edition. 210 1$aOxfordshire, [England] :$cOxford University Press,$d2015. 210 4$dİ2015 215 $a1 online resource (585 p.) 300 $aDescription based upon print version of record. 311 $a0-19-967161-3 311 $a1-322-20643-0 320 $aIncludes bibliographical references and index at the end of each chapters. 327 $aCover; Imaging in Neurodegenerative Disorders; Copyright; Dedication; Contents; List of abbreviations; List of contributors; SECTION 1 Introduction; 1 Epidemiology of neurodegenerative diseases; 2 Metabolomics of neurodegenerative disorders; 3 Transcriptome profiling in neurodegenerative disorders; 4 Health economic considerations in neurodegenerative disorders; 5 Symptoms of neurodegenerative diseases; SECTION 2 Imaging technique; 6 Computed tomography; 7 General principles of magnetic resonance imaging; 8 Nuclear medicine and radiology; 9 Molecular imaging and neurodegenerative disorders 327 $a10 Positron emission tomography in neurodegenerative disorders-evolving techniques and new tracers11 Radiopharmaceuticals for molecular imaging of neurodegenerative diseases; SECTION 3 Neurodegeneration: cognition; 12 Neuroimaging of Alzheimer's disease; 13 MRI-based imaging of Alzheimer's disease; 14 Frontotemporal dementia; 15 Dementia with Lewy bodies; 16 Corticobasal syndrome and corticobasal degeneration; SECTION 4 Neurodegeneration: movement; 17 Parkinson's disease: clinical and imaging features; 18 Progressive supranuclear palsy; 19 Imaging in Huntington's disease 327 $a20 Multiple system atrophy21 Clinical benefit of dopamine transporter imaging in movement disorders and dementia; SECTION 5 Neurodegeneration: strength; 22 Amyotrophic lateral sclerosis; SECTION 6 Neurodegeneration: coordination; 23 Spinocerebellar atrophies; 24 Imaging in Friedreich's ataxia; 25 Neuroimaging in human prion diseases; SECTION 7 Neurodegeneration: peripheral and autonomic nervous systems; 26 Amyloidosis; 27 Neurodegeneration: metabolic and toxin-related disorders; SECTION 8 Neurodegeneration: myelin; 28 Demyelinating diseases; 29 Charcot-Marie-Tooth disease 327 $a30 Neurodegenerative disorders of the basal gangliaSECTION 9 Neurodegeneration: trauma; 31 Neurodegeneration post trauma: brain; 32 Neurodegeneration post trauma: spine; 33 Neurodegeneration after trauma: peripheral nerves; SECTION 10 Neuroimaging after therapy; 34 Functional imaging of neurosurgery in Parkinson's disease; 35 Neuroimaging after cell-based therapy; Index 330 $aDiagnosing neurodegenerative diseases can prove particularly intimidating to clinicians, because many times the diagnosis cannot be critically ""confirmed"" by a simple test. New imaging modalities have advanced to the point of high resolution, morphological, metabolic and functional analysis. Computed tomography, magnetic resonance, nuclear medicine and molecular imaging have recently emerged as outstanding non-invasive techniques for the study of theneurodegenerative disorders. Imaging in Neurodegenerative Disorders covers all the imaging techniques and new exciting methods like new tracers, 606 $aNervous system$xDegeneration 606 $aBrain$xDegeneration 608 $aElectronic books. 615 0$aNervous system$xDegeneration. 615 0$aBrain$xDegeneration. 676 $a616.8047 702 $aSaba$b Luca 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910463842803321 996 $aImaging in neurodegenerative disorders$91913768 997 $aUNINA LEADER 02177nam 2200457 450 001 9910138262303321 005 20230920194008.0 010 $a953-51-4490-1 035 $a(CKB)3230000000075686 035 $a(NjHacI)993230000000075686 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/42304 035 $a(EXLCZ)993230000000075686 100 $a20221021d2011 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aBiotechnology of biopolymers /$fedited by Magdy Elnashar 210 $cIntechOpen$d2011 210 1$aRijeka, Croatia :$cIntechOpen,$d[2011] 210 4$dİ2011 215 $a1 online resource (378 pages) $cillustrations 311 $a953-307-179-6 320 $aIncludes bibliographical references. 330 $aThe book “Biotechnology of Biopolymers” comprises 17 chapters covering occurrence, synthesis, isolation and production, properties and applications, biodegradation and modification, the relevant analysis methods to reveal the structures and properties of biopolymers and a special section on the theoretical, experimental and mathematical models of biopolymers. This book will hopefully be supportive to many scientists, physicians, pharmaceutics, engineers and other experts in a wide variety of different disciplines, in academia and in industry. It may not only support research and development but may be also suitable for teaching. Publishing of this book was achieved by choosing authors of the individual chapters for their recognized expertise and for their excellent contributions to the various fields of research. 606 $aBiopolymers$xBiotechnology 610 $aPhysical Sciences 610 $aEngineering and Technology 610 $aMaterials Science 610 $aPolymers 610 $aBiomaterials 615 0$aBiopolymers$xBiotechnology. 676 $a660.6 702 $aElnashar$b Magdy 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910138262303321 996 $aBiotechnology of Biopolymers$92276316 997 $aUNINA LEADER 01112nam 2200397z- 450 001 9910477053703321 005 20251116142441.0 024 7 $a10.22459/PE.2020 035 $a(CKB)5470000000569405 035 $a(OCoLC)1178915122 035 $a(EXLCZ)995470000000569405 100 $a20210608d2020uuuu mu 0 101 0 $aeng 135 $aurbn#---aa||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 12$aA Populist Exception? $eThe 2017 New Zealand General Election / Edited By Jack Vowles and Jennifer Curtin 210 $aCanberra $cANU Press$d2020 215 $a1 online resource $cillustrations 311 08$aPrint: 9781760463854 607 $aNew Zealand$2fast 610 5$aNew Zealand 610 0$aElections & referenda 610 0$apopulism 610 0$apolitics 610 0$aelections 610 0$aauthoritarianism 610 0$ainclusivity 610 0 $avote choice 702 $aVowles$b Jack 702 $aCurtin$b Jennifer 906 $aBOOK 912 $a9910477053703321 996 $aA Populist Exception$92872259 997 $aUNINA